Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sally H. Pattison, David S. Gibson, Elinor Johnston, Samantha Peacock, Keith Rivera, Michael M. Tunney, Darryl J. Pappin, J. Stuart Elborn. Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa. Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis Source: Eur Respir J 2009; 33: 305-311 Year: 2009 Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis Source: Eur Respir J 2011; 37: 553-558 Year: 2011 Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis Source: Eur Respir J 2004; 24 : 631-637 Year: 2004 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells Source: ERJ Open Res, 3 (1) 00095-2016; 10.1183/23120541.00095-2016 Year: 2017 Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis Source: Eur Respir J 2013; 42: 1723-1736 Year: 2013 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Highly concentrated aerosolized tobramycin in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Training dogs to differentiate Pseudomonas aeruginosa from other cystic fibrosis bacterial pathogens: not to be sniffed at? Source: Eur Respir J, 54 (5) 1900970; 10.1183/13993003.00970-2019 Year: 2019